Clinical Trial: An Open-Label PET/CT Imaging Study to Evaluate Brain Serotonin Transporter (SERT) Occupancy Following Single-Dose Administration of LG-0317 Tablets in Healthy Participants

U.S., July 17 -- ClinicalTrials.gov registry received information related to the study (NCT07708428) titled 'An Open-Label PET/CT Imaging Study to Evaluate Brain Serotonin Transporter (SERT) Occupancy Following Single-Dose Administration of LG-0317 Tablets in Healthy Participants' on July 13.

Brief Summary: The purpose of the study is to evaluate brain serotonin transporter (SERT) receptor occupancy (RO) following single oral doses of LG-0317 tablets in healthy male participants; and to explore the pharmacokinetic/pharmacodynamic (PK/PD) relationship between LG-0317 plasma concentrations and SERT occupancy..

Study Start Date: July 24

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers (HV)

Intervention: DRUG: Cohort 1: LG-0317 2...